Guardian Pharmacy Services Inc
Exchange: NYSESector: HealthcareIndustry: Medical Care Facilities
Guardian Pharmacy Services Inc
Current Price
$36.61
+0.94%GoodMoat Value
$71.39
95.0% undervaluedProfile
Valuation (TTM)
Market Cap$2.32B
P/E43.68
EV—
P/B11.27
Shares Out63.32M
P/Sales1.59
Revenue$1.46B
EV/EBITDA22.42
Guardian Pharmacy Services Inc (GRDN) Stock Analysis
Market Cap$2.32B
Current Price$36.61
P/E Ratio43.68
Forward P/E—
PEG Ratio1.09
EPS$0.78
Book Value$3.25
P/B Ratio11.27
GRDN Financial Charts
FCF vs CAPEX
FCFCAPEX
Forward estimates use 36.5% FCF growth (CAGR)
Cash vs Debt
Net Cash: 28M
Revenue
909M
FY22
1.0B
FY23
1.2B
FY24
1.4B
FY25
Net Income
35M
FY22
—
FY23
—
FY24
49M
FY25
GRDN 52-Week Range
$19.67
$40.65
50-Day MA: $36.39200-Day MA: $30.45
Did you know?
Trading 95% below its estimated fair value of $71.39.
Guardian Pharmacy Services Inc (GRDN) Financial Summary
Guardian Pharmacy Services Inc (GRDN) is a Healthcare company in the Medical Care Facilities industry, listed on NYSE. The stock currently trades at $36.61 with a market capitalization of $2.32B.
Key valuation metrics include a P/E ratio of 43.68, price-to-book ratio of 11.27, and EPS of $0.78. The company reports a profit margin of 3.6% and return on equity of 25.8%.
GRDN Key Financial Metrics
| Metric | Value |
|---|---|
| Market Cap | $2.32B |
| P/E Ratio | 43.68 |
| EPS | $0.78 |
| P/B Ratio | 11.27 |
| P/S Ratio | 1.59 |
| EV/EBITDA | 22.42 |
| Profit Margin | 3.6% |
| Return on Equity | 25.8% |
| Debt/Equity | 0.18 |
GRDN Revenue & Earnings History
| Year | Revenue | Net Income |
|---|---|---|
| FY22 | $908.91M | $35.42M |
| FY23 | $1.05B | $0.00 |
| FY24 | $1.23B | $-110.05M |
| FY25 | $1.45B | $49.22M |
Guardian Pharmacy Services Inc (GRDN) Valuation
Based on GoodMoat's DCF model, Guardian Pharmacy Services Inc has a fair value estimate of $71.39. At the current price of $36.61, the stock appears 48.7% undervalued relative to our intrinsic value estimate.
GRDN Quality Indicators
Guardian Pharmacy Services Inc maintains a profit margin of 3.6% and an operating margin of 5.1%. Return on equity stands at 25.8%. The current ratio is 1.38. Debt-to-equity ratio is 0.18.
About Guardian Pharmacy Services Inc
Guardian Pharmacy Services Inc
GRDN Free Cash Flow
Guardian Pharmacy Services Inc generated $80.71M in trailing twelve-month free cash flow, representing an FCF yield of 3.48%. This moderate FCF yield indicates reasonable cash generation.
GRDN Shares Outstanding
Guardian Pharmacy Services Inc has 0.06 billion shares outstanding at a share price of $36.61, giving it a market capitalization of $2.32B.